Immunotherapy: Open Access

Immunotherapy: Open Access
Open Access

ISSN: 2471-9552

Short Communication - (2017) Volume 3, Issue 1

IL4I1: An Emerging Target to Reinvigorate Antitumor Immune Responses

Flavia Castellano1,2,3 and Valérie Molinier-Frenkel1,2,4*
1INSERM, U955, Equipe 09, Créteil, France
2Université Paris Est, Faculty of Medicine, Créteil, France
3AP-HP, Hôpital H. Mondor - A. Chenevier, Biological Resources Platform, Créteil, France
4AP-HP, Hôpital H. Mondor - A. Chenevier, Service d’Immunologie Biologique, Créteil, France
*Corresponding Author: Valérie Molinier-Frenkel, INSERM U955, IMRB eq 09, Hôpital Henri Mondor, 51 Av Du Maréchal De Lattre De Tassigny, F-94010, Créteil Cedex, France, Tel: +33 1 49 81 37 65, Fax: +33 1 49 81 35 66 Email:

Keywords: B-cell; Tumour; Lymphoma; Immunotherapy

Short Communication